{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:15:59Z","timestamp":1782281759071,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.biopha.2020.110509","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T05:26:20Z","timestamp":1594272380000},"page":"110509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Emerging roles of non-coding RNAs in the pathogenesis of type 1 diabetes mellitus"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-0591","authenticated-orcid":false,"given":"Mohammad","family":"Taheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhane","family":"Eghtedarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel E.","family":"Dinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110509_bib0005","first-page":"1","article-title":"An overview of the epidemiology of type 1 Diabetes Mellitus","volume":"2","author":"Shojaeian","year":"2018","journal-title":"Int. J. Metab. Syndromes"},{"key":"10.1016\/j.biopha.2020.110509_bib0010","series-title":"Type 1 Diabetes in the Young: The Harvest of Sorrow Goes on","author":"Gale","year":"2005"},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s001250051578","article-title":"Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index","volume":"44","author":"Weets","year":"2001","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.biopha.2020.110509_bib0020","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.2337\/diacare.27.8.1985","article-title":"Male sex increases the risk of autoimmunity but not type 1 diabetes","volume":"27","author":"Krischer","year":"2004","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007732","article-title":"Genetics of type 1 diabetes","volume":"2","author":"Noble","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"11","key":"10.1016\/j.biopha.2020.110509_bib0030","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007641","article-title":"The pathogenesis and natural history of type 1 diabetes","volume":"2","author":"Atkinson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2020.110509_bib0035","series-title":"Pancreatic Pathology in Type 1 Diabetes in Human. Novartis Foundation Symposium","year":"2008"},{"issue":"9","key":"10.1016\/j.biopha.2020.110509_bib0040","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbagrm.2015.08.005","article-title":"The specificity of long noncoding RNA expression","volume":"1859","author":"Gloss","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13059-017-1348-2","article-title":"The multidimensional mechanisms of long noncoding RNA function","volume":"18","author":"Marchese","year":"2017","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110509_bib0055","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12253-019-00614-3","article-title":"MEG3: an oncogenic long non-coding RNA in different cancers","volume":"25","author":"Al-Rugeebah","year":"2019","journal-title":"Pathol. Oncol. Res."},{"issue":"5","key":"10.1016\/j.biopha.2020.110509_bib0060","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1159\/000487983","article-title":"Long Noncoding RNA Meg3 Regulates Mafa Expression in Mouse Beta Cells by Inactivating Rad21, Smc3 or Sin3alpha","volume":"45","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.biopha.2020.110509_bib0065","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cub.2005.02.027","article-title":"The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina","volume":"15","author":"Young","year":"2005","journal-title":"Curr. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110509_bib0070","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1159\/000373999","article-title":"Downregulation of lncRNA TUG1 affects apoptosis and insulin secretion in mouse pancreatic beta cells","volume":"35","author":"Yin","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"23","key":"10.1016\/j.biopha.2020.110509_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235903","article-title":"Profiling of RNAs from human islet-derived exosomes in a model of type 1 diabetes","volume":"20","author":"Krishnan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.110509_bib0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbr.2016.03.023","article-title":"Autophagy ameliorates cognitive impairment through activation of PVT1 and apoptosis in diabetes mice","volume":"305","author":"Li","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.biopha.2020.110509_bib0085","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1159\/000487983","article-title":"Long noncoding RNA Meg3 regulates mafa expression in mouse beta cells by inactivating Rad21, Smc3 or Sin3\u03b1","volume":"45","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2020.110509_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104432","article-title":"LncRNA MALAT1 induces the dysfunction of \u03b2 cells via reducing the histone acetylation of the PDX-1 promoter in type 1 diabetes","author":"Ding","year":"2020","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.biopha.2020.110509_bib0095","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9275106","article-title":"Insights from lncRNAs Profiling of MIN6 Beta Cells Undergoing Inflammation","volume":"2016","author":"Sun","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.biopha.2020.110509_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104432","article-title":"LncRNA MALAT1 induces the dysfunction of beta cells via reducing the histone acetylation of the PDX-1 promoter in type 1 diabetes","volume":"114","author":"Ding","year":"2020","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.biopha.2020.110509_bib0105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1914353117","article-title":"The T1D-associated lncRNA Lnc13 modulates human pancreatic beta cell inflammation by allele-specific stabilization of STAT1 mRNA","author":"Gonzalez-Moro","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biopha.2020.110509_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2019.03.006","article-title":"A long noncoding RNA LOC103690121 promotes hippocampus neuronal apoptosis in streptozotocin-induced type 1 diabetes","volume":"703","author":"Hao","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.biopha.2020.110509_bib0115","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00125-015-3641-5","article-title":"Involvement of long non-coding RNAs in beta cell failure at the onset of type 1 diabetes in NOD mice","volume":"58","author":"Motterle","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2020.110509_bib0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-019-0523-z","article-title":"The emerging roles and functions of circular RNAs and their generation","author":"Yu","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2020.110509_bib0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molmet.2018.01.010","article-title":"Circular RNAs as novel regulators of beta-cell functions in normal and disease conditions","volume":"9","author":"Stoll","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.biopha.2020.110509_bib0130","first-page":"5","article-title":"The long noncoding RNA MALAT1 predicts human pancreatic islet isolation quality","author":"Wong","year":"2019","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.biopha.2020.110509_bib0135","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.2337\/db07-0675","article-title":"Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes","volume":"56","author":"Millis","year":"2007","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng.493","article-title":"The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes","volume":"42","author":"Wallace","year":"2010","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00125-019-05026-1","article-title":"miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes","volume":"63","author":"Ventriglia","year":"2020","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.lfs.2013.12.199","article-title":"Chakrabarti S. miRNA-1 regulates endothelin-1 in diabetes","volume":"98","author":"Feng","year":"2014","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191067","article-title":"Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes","volume":"13","author":"Akerman","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2020.110509_bib0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020477","article-title":"Blood Co-circulating extracellular microRNAs and immune cell subsets associate with type 1 diabetes severity","volume":"21","author":"Garavelli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2020.110509_bib0165","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2337\/db17-1207","article-title":"Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes","volume":"67","author":"Satake","year":"2018","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.biopha.2020.110509_bib0170","doi-asserted-by":"crossref","first-page":"E1661","DOI":"10.1210\/jc.2013-3868","article-title":"Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study","volume":"99","author":"Osipova","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2020.110509_bib0175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fgene.2019.00563","article-title":"MiR-30e-5p and MiR-15a-5p expressions in plasma and urine of type 1 diabetic patients with diabetic kidney disease","volume":"10","author":"Dieter","year":"2019","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0180","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1038\/s41598-017-05787-y","article-title":"Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes","volume":"7","author":"Garcia-Contreras","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2020.110509_bib0185","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbrc.2017.06.196","article-title":"Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: association with ongoing islet autoimmunity","volume":"498","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2020.110509_bib0190","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.imbio.2012.08.276","article-title":"MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes","volume":"218","author":"Salas-Perez","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopha.2020.110509_bib0195","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8406438","article-title":"Decreased serum microRNA-21, microRNA-25, microRNA-146a, and microRNA-181a in autoimmune diabetes: potential biomarkers for diagnosis and possible involvement in pathogenesis","volume":"2019","author":"Liu","year":"2019","journal-title":"Int. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110509_bib0200","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/pedi.12783","article-title":"Temporal dynamics of serum let-7g expression mirror the decline of residual beta-cell function in longitudinal observation of children with type 1 diabetes","volume":"19","author":"Malachowska","year":"2018","journal-title":"Pediatr. Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2020.110509_bib0205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cellimm.2009.10.012","article-title":"microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients","volume":"260","author":"Hezova","year":"2010","journal-title":"Cell. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2020.110509_bib0210","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00137.2012","article-title":"Hollander JM. miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart","volume":"303","author":"Baseler","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110509_bib0215","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00125-015-3622-8","article-title":"Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL\/6 mice","volume":"58","author":"Zheng","year":"2015","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.biopha.2020.110509_bib0220","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00137.2012","article-title":"miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart","volume":"303","author":"Baseler","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0225","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/ijn.IJN_80_19","article-title":"MicroRNA-21 as an early marker of nephropathy in patients with type 1 diabetes","volume":"30","author":"Fouad","year":"2020","journal-title":"Indian J. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110509_bib0230","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1210\/en.2012-1744","article-title":"Circulating miR-375 as a biomarker of beta-cell death and diabetes in mice","volume":"154","author":"Erener","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2020.110509_bib0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.diabres.2018.03.044","article-title":"MicroRNA expression profile in plasma from type 1 diabetic patients: Case-control study and bioinformatic analysis","volume":"141","author":"Assmann","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"7","key":"10.1016\/j.biopha.2020.110509_bib0240","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/db11-1086","article-title":"Changes in microRNA expression contribute to pancreatic beta-cell dysfunction in prediabetic NOD mice","volume":"61","author":"Roggli","year":"2012","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.biopha.2020.110509_bib0245","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/labinvest.2015.112","article-title":"miR-101a and miR-30b contribute to inflammatory cytokine-mediated beta-cell dysfunction","volume":"95","author":"Zheng","year":"2015","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.biopha.2020.110509_bib0250","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3892\/br.2015.426","article-title":"Cross-talks between microRNAs and mRNAs in pancreatic tissues of streptozotocin-induced type 1 diabetic mice","volume":"3","author":"Tian","year":"2015","journal-title":"Biomed. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2020.110509_bib0255","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1167\/iovs.12-10921","article-title":"MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model","volume":"54","author":"Murray","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2020.110509_bib0260","first-page":"2717","article-title":"miR-192 is upregulated in T1D, regulates pancreatic beta-cell development and inhibits insulin secretion through suppressing GLP-1 expression","volume":"16","author":"Pan","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2020.110509_bib0265","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3389\/fimmu.2019.01637","article-title":"Increased expression of circulating microRNA 101-3p in type 1 diabetes patients: new insights into miRNA-Regulated pathophysiological pathways for type 1 diabetes","volume":"10","author":"Santos","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110509_bib0270","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00122.2019","article-title":"Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell loss","volume":"317","author":"Xu","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2020.110509_bib0275","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arcmed.2019.07.002","article-title":"Expression Pattern of microRNAs, miR-21, miR-155 and miR-338 in Patients with Type 1 Diabetes","volume":"50","author":"Mostahfezian","year":"2019","journal-title":"Arch. Med. Res."},{"issue":"6","key":"10.1016\/j.biopha.2020.110509_bib0280","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s11033-018-4352-z","article-title":"Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetes","volume":"45","author":"Azhir","year":"2018","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2020.110509_bib0285","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89656","article-title":"Profiling of circulating microRNAs in children with recent onset of type 1 diabetes","volume":"2","author":"Erener","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.biopha.2020.110509_bib0290","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1210\/jc.2017-01417","article-title":"Two novel MicroRNA biomarkers related to beta-cell damage and their potential values for early diagnosis of type 1 diabetes","volume":"103","author":"Liu","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2020.110509_bib0295","article-title":"Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression","volume":"2012","author":"Nielsen","year":"2012","journal-title":"Exp. Diabetes Res."},{"issue":"6","key":"10.1016\/j.biopha.2020.110509_bib0300","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/gene.2016.29","article-title":"Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes","volume":"17","author":"de Jong","year":"2016","journal-title":"Genes Immun."},{"issue":"11","key":"10.1016\/j.biopha.2020.110509_bib0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142688","article-title":"Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice","volume":"10","author":"Fornari","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2020.110509_bib0310","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1038\/s41598-017-07172-1","article-title":"Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression","volume":"7","author":"Sebastiani","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2020.110509_bib0315","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/genes6020399","article-title":"MicroRNA-224 is readily detectable in urine of individuals with diabetes mellitus and is a potential Indicator of beta-cell demise","volume":"6","author":"Bacon","year":"2015","journal-title":"Genes"},{"issue":"11","key":"10.1016\/j.biopha.2020.110509_bib0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073798","article-title":"Urinary exosomal microRNAs in incipient diabetic nephropathy","volume":"8","author":"Barutta","year":"2013","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.biopha.2020.110509_bib0325","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1177\/1535370217716424","article-title":"Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia","volume":"242","author":"Chen","year":"2017","journal-title":"Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2020.110509_bib0330","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1007\/s12035-017-0398-5","article-title":"Effects of TRPM7\/miR-34a gene silencing on spatial cognitive function and hippocampal neurogenesis in mice with type 1 diabetes mellitus","volume":"55","author":"Zhang","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110509_bib0335","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cmet.2012.08.010","article-title":"Human \u03b2 cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes","volume":"16","author":"Mor\u00e1n","year":"2012","journal-title":"Cell Metab."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220307022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220307022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:18:25Z","timestamp":1760098705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220307022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":67,"alternative-id":["S0753332220307022"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110509","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging roles of non-coding RNAs in the pathogenesis of type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110509"}}